BEND, Ore., Jan. 02, 2018 (GLOBE NEWSWIRE) -- EVIO, Inc. (OTCQB:EVIO), a life sciences company and leading provider of quality control testing and advisory services to the regulated cannabis industry, announced today that it completed the acquisition of 60% of C3 Labs, LLC. EVIO also has the ...
read more here
Delivered by @can_nab_is
No comments:
Post a Comment